captopril has been researched along with osteoprotegerin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alaam, MM; Hussien, NI | 1 |
| Chen, XF; Li, XL; Liu, JX; Xu, J; Yang, M; Zhang, Y; Zhao, YY | 1 |
2 other study(ies) available for captopril and osteoprotegerin
| Article | Year |
|---|---|
A comparative study between the effect of 17-β estradiol and angiotensin converting enzyme inhibitor on osteoporosis in ovariectomized rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcification, Physiologic; Captopril; Estradiol; Estrogens; Female; Femur; Humans; Osteoporosis, Postmenopausal; Osteoprotegerin; Ovariectomy; RANK Ligand; Rats; Treatment Outcome | 2016 |
Inhibition on angiotensin-converting enzyme exerts beneficial effects on trabecular bone in orchidectomized mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Bone Density; Cancellous Bone; Captopril; Carbonic Anhydrase II; Dose-Response Relationship, Drug; Femur; Lumbar Vertebrae; Male; Matrix Metalloproteinase 9; Mice; Orchiectomy; Osteoprotegerin; Proton-Translocating ATPases; RANK Ligand; Receptor, Bradykinin B1; Receptors, Cell Surface; Renin-Angiotensin System; Tibia; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2018 |